BRYNELSEN CHARLES 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2021
Insider Transaction Report
Form 4
BRYNELSEN CHARLES
Senior Vice President
Transactions
- Award
Common shares without par value
2021-02-19+7,802→ 51,612 total - Award
Option (right to buy)
2021-02-19+39,994→ 39,994 totalExercise: $124.04From: 2022-02-19Exp: 2031-02-18→ Common Shares (39,994 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,331 on February 19, 2022, 13,331 on February 19, 2023, and 13,332 on February 19, 2024.